Oppenheimer Asset Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-1,592
| Closed | -$150K | – | 1430 |
|
|
2020
Q1 | $150K | Sell |
1,592
-11
| -0.7% | -$1.04K | ﹤0.01% | 1025 |
|
|
2019
Q4 | $173K | Sell |
1,603
-21
| -1% | -$2.27K | ﹤0.01% | 1087 |
|
|
2019
Q3 | $156K | Buy |
1,624
+23
| +1% | +$2.21K | ﹤0.01% | 1091 |
|
|
2019
Q2 | $153K | Buy |
1,601
+158
| +11% | +$15.1K | ﹤0.01% | 1116 |
|
|
2019
Q1 | $127K | Buy |
1,443
+45
| +3% | +$3.96K | ﹤0.01% | 1150 |
|
|
2018
Q4 | $116K | Buy |
+1,398
| New | +$116K | ﹤0.01% | 1154 |
|
|
2017
Q4 | – | Sell |
-907
| Closed | -$67K | – | 1477 |
|
|
2017
Q3 | $67K | Buy |
907
+99
| +12% | +$7.31K | ﹤0.01% | 1300 |
|
|
2017
Q2 | $58K | Buy |
808
+463
| +134% | +$33.2K | ﹤0.01% | 1313 |
|
|
2017
Q1 | $21K | Buy |
+345
| New | +$21K | ﹤0.01% | 1470 |
|